Effectiveness of a scalable group-based education and monitoring program, delivered by health workers, to improve control of hypertension in rural India: A cluster randomised controlled trial.


Journal

PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360

Informations de publication

Date de publication:
01 2020
Historique:
received: 30 04 2019
accepted: 06 12 2019
entrez: 3 1 2020
pubmed: 3 1 2020
medline: 17 4 2020
Statut: epublish

Résumé

New methods are required to manage hypertension in resource-poor settings. We hypothesised that a community health worker (CHW)-led group-based education and monitoring intervention would improve control of blood pressure (BP). We conducted a baseline community-based survey followed by a cluster randomised controlled trial of people with hypertension in 3 rural regions of South India, each at differing stages of epidemiological transition. Participants with hypertension, defined as BP ≥ 140/90 mm Hg or taking antihypertensive medication, were advised to visit a doctor. In each region, villages were randomly assigned to intervention or usual care (UC) in a 1:2 ratio. In intervention clusters, trained CHWs delivered a group-based intervention to people with hypertension. The program, conducted fortnightly for 3 months, included monitoring of BP, education about hypertension, and support for healthy lifestyle change. Outcomes were assessed approximately 2 months after completion of the intervention. The primary outcome was control of BP (BP < 140/90 mm Hg), analysed using mixed effects regression, clustered by village within region and adjusted for baseline control of hypertension (using intention-to-treat principles). Of 2,382 potentially eligible people, 637 from 5 intervention clusters and 1,097 from 10 UC clusters were recruited between November 2015 and April 2016, with follow-up occurring in 459 in the intervention group and 1,012 in UC. Mean age was 56.9 years (SD 13.7). Baseline BP was similar between groups. Control of BP improved from baseline to follow-up more in the intervention group (from 227 [49.5%] to 320 [69.7%] individuals) than in the UC group (from 528 [52.2%] to 624 [61.7%] individuals) (odds ratio [OR] 1.6, 95% CI 1.2-2.1; P = 0.001). In secondary outcome analyses, there was a greater decline in systolic BP in the intervention than UC group (-5.0 mm Hg, 95% CI -7.1 to -3.0; P < 0.001) and a greater decline in diastolic BP (-2.1 mm Hg, 95% CI -3.6 to -0.6; P < 0.006), but no detectable difference in the use of BP-lowering medications between groups (OR 1.2, 95% CI 0.8-1.9; P = 0.34). Similar results were found when using imputation analyses that included those lost to follow-up. Limitations include a relatively short follow-up period and use of outcome assessors who were not blinded to the group allocation. While the durability of the effect is uncertain, this trial provides evidence that a low-cost program using CHWs to deliver an education and monitoring intervention is effective in controlling BP and is potentially scalable in resource-poor settings globally. The trial was registered with the Clinical Trials Registry-India (CTRI/2016/02/006678).

Sections du résumé

BACKGROUND
New methods are required to manage hypertension in resource-poor settings. We hypothesised that a community health worker (CHW)-led group-based education and monitoring intervention would improve control of blood pressure (BP).
METHODS AND FINDINGS
We conducted a baseline community-based survey followed by a cluster randomised controlled trial of people with hypertension in 3 rural regions of South India, each at differing stages of epidemiological transition. Participants with hypertension, defined as BP ≥ 140/90 mm Hg or taking antihypertensive medication, were advised to visit a doctor. In each region, villages were randomly assigned to intervention or usual care (UC) in a 1:2 ratio. In intervention clusters, trained CHWs delivered a group-based intervention to people with hypertension. The program, conducted fortnightly for 3 months, included monitoring of BP, education about hypertension, and support for healthy lifestyle change. Outcomes were assessed approximately 2 months after completion of the intervention. The primary outcome was control of BP (BP < 140/90 mm Hg), analysed using mixed effects regression, clustered by village within region and adjusted for baseline control of hypertension (using intention-to-treat principles). Of 2,382 potentially eligible people, 637 from 5 intervention clusters and 1,097 from 10 UC clusters were recruited between November 2015 and April 2016, with follow-up occurring in 459 in the intervention group and 1,012 in UC. Mean age was 56.9 years (SD 13.7). Baseline BP was similar between groups. Control of BP improved from baseline to follow-up more in the intervention group (from 227 [49.5%] to 320 [69.7%] individuals) than in the UC group (from 528 [52.2%] to 624 [61.7%] individuals) (odds ratio [OR] 1.6, 95% CI 1.2-2.1; P = 0.001). In secondary outcome analyses, there was a greater decline in systolic BP in the intervention than UC group (-5.0 mm Hg, 95% CI -7.1 to -3.0; P < 0.001) and a greater decline in diastolic BP (-2.1 mm Hg, 95% CI -3.6 to -0.6; P < 0.006), but no detectable difference in the use of BP-lowering medications between groups (OR 1.2, 95% CI 0.8-1.9; P = 0.34). Similar results were found when using imputation analyses that included those lost to follow-up. Limitations include a relatively short follow-up period and use of outcome assessors who were not blinded to the group allocation.
CONCLUSIONS
While the durability of the effect is uncertain, this trial provides evidence that a low-cost program using CHWs to deliver an education and monitoring intervention is effective in controlling BP and is potentially scalable in resource-poor settings globally.
TRIAL REGISTRATION
The trial was registered with the Clinical Trials Registry-India (CTRI/2016/02/006678).

Identifiants

pubmed: 31895945
doi: 10.1371/journal.pmed.1002997
pii: PMEDICINE-D-19-01554
pmc: PMC6939905
doi:

Banques de données

CTRI
['CTRI/2016/02/006678']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1002997

Déclaration de conflit d'intérêts

I have read the journal's policy and the authors of this manuscript have the following competing interests: CKC reports grants from the National Health and Medical Research Council (NHMRC) and National Heart Foundation, outside the submitted work; RGE reports grants from the NHMRC, during the conduct of the study. KKal, KKar and AGT report grants from NHMRC for this study and for other projects outside the submitted work; RKG reports a grant from the European Commission and the Ministry of Science and Higher Education, Republic of Poland under the H2020-MSCA-COFUND-2016-DP Grant (Grant Agreement No. 754432). RKG reports being a stock holder in three Indian multinational pharmaceutical (Ajanta Pharma Limited, Divi’s Laboratories Limited, and NATCO Pharma Limited); no other relationships or activities that could appear to have influenced the submitted work exist.

Références

J Hum Hypertens. 2016 Feb;30(2):79-82
pubmed: 26108364
Ann Intern Med. 2009 Nov 3;151(9):593-601
pubmed: 19884620
Indian Heart J. 2008 Jan-Feb;60(1):19-25
pubmed: 19212017
J Assoc Physicians India. 2007 May;55:323-4
pubmed: 17844690
BMJ Glob Health. 2018 Feb 15;3(1):e000566
pubmed: 29527344
J Hypertens. 2014 Jun;32(6):1170-7
pubmed: 24621804
Hypertension. 2009 Oct;54(4):756-62
pubmed: 19704106
Lancet. 2017 Jan 7;389(10064):37-55
pubmed: 27863813
JAMA. 2017 Jan 10;317(2):165-182
pubmed: 28097354
J Hypertens. 2011 Mar;29(3):443-50
pubmed: 21119531
BMC Health Serv Res. 2018 May 2;18(1):320
pubmed: 29720161
QJM. 2013 Oct;106(10):909-14
pubmed: 23696676
PLoS Med. 2009 May 26;6(5):e1000065
pubmed: 19536323
J Hypertens. 2016 Sep;34(9):1872-81
pubmed: 27488552
JAMA. 2017 Sep 19;318(11):1016-1025
pubmed: 28975305
BMJ Open. 2016 Oct 8;6(10):e012404
pubmed: 27855099
PLoS One. 2014 Aug 14;9(8):e103754
pubmed: 25121789
J Hum Hypertens. 2017 May;31(5):347-353
pubmed: 28054571
Contemp Clin Trials. 2005 Apr;26(2):260-7
pubmed: 15837446
Bull World Health Organ. 2010 Jun;88(6):412-9
pubmed: 20539854
Lancet Glob Health. 2018 Jan;6(1):e66-e73
pubmed: 29241617
Psychol Res Behav Manag. 2013 Aug 19;6:55-63
pubmed: 23983496
Lancet Public Health. 2017 Sep;2(9):e411-e419
pubmed: 29253412
PLoS One. 2019 Mar 26;14(3):e0213708
pubmed: 30913216
Diabetes Educ. 2010 Nov-Dec;36(6):936-44
pubmed: 20974905
Lancet. 2003 Nov 8;362(9395):1527-35
pubmed: 14615107
Acta Med Scand. 1986;219(3):261-9
pubmed: 3486551

Auteurs

Dilan Giguruwa Gamage (DG)

Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia.

Michaela A Riddell (MA)

Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia.

Rohina Joshi (R)

George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
University of Sydney, Sydney, New South Wales, Australia.
George Institute for Global Health, New Delhi, India.

Kavumpurathu R Thankappan (KR)

Achutha Menon Centre for Health Science Studies, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.

Clara K Chow (CK)

George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
University of Sydney, Sydney, New South Wales, Australia.
Department of Cardiology, Westmead Hospital, Sydney, New South Wales, Australia.

Brian Oldenburg (B)

Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.

Roger G Evans (RG)

Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Physiology, Monash University, Melbourne, Victoria, Australia.

Ajay S Mahal (AS)

School of Public Health and Preventative Medicine, Monash University, Melbourne, Victoria, Australia.
Nossal Institute for Global Health, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.

Kartik Kalyanram (K)

Rishi Valley Rural Health Centre, Chittoor District, Andhra Pradesh, India.

Kamakshi Kartik (K)

Rishi Valley Rural Health Centre, Chittoor District, Andhra Pradesh, India.

Oduru Suresh (O)

Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia.
Rishi Valley Rural Health Centre, Chittoor District, Andhra Pradesh, India.

Nihal Thomas (N)

Department of Endocrinology, Diabetes & Metabolism, Christian Medical College, Vellore, Tamil Nadu, India.

Gomathyamma K Mini (GK)

Achutha Menon Centre for Health Science Studies, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
Global Institute of Public Health, Ananthapuri Hospitals and Research Institute, Trivandrum, Kerala, India.

Pallab K Maulik (PK)

George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
George Institute for Global Health, New Delhi, India.
George Institute for Global Health, Oxford University, Oxford, United Kingdom.

Velandai K Srikanth (VK)

Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia.
Peninsula Clinical School, Central Clinical School, Monash University, Frankston, Victoria, Australia.

Simin Arabshahi (S)

Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia.

Ravi P Varma (RP)

Achutha Menon Centre for Health Science Studies, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.

Rama K Guggilla (RK)

George Institute for Global Health, New Delhi, India.
Department of Population Medicine and Civilization Diseases Prevention, Faculty of Medicine, Division of Dentistry and Division of Medical Education in English, Medical University of Bialystok, Bialystok, Poland.

Fabrizio D'Esposito (F)

Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.

Thirunavukkarasu Sathish (T)

Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
Centre for Population Health Sciences, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

Mohammed Alim (M)

George Institute for Global Health, New Delhi, India.
University of Central Lancashire, Preston, United Kingdom.

Amanda G Thrift (AG)

Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH